FDA Approved: DAPAGLIFLOZIN — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved the original application for dapagliflozin from Zydus Lifesciences Limited, making a generic SGLT2 inhibitor available for glycemic control in adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

ORIG AP for DAPAGLIFLOZIN (DAPAGLIFLOZIN)